Persistent smokers after myocardial infarction: A group that requires special attention

International Journal of Cardiology

Volumn 100, Issue 2, 2005, Pages 241-245

  Rallidis, Loukianos S ^a,b   Hamodraka, Eftichia S ^a   Foulidis, Valerios O ^a   Pavlakis, Georgios P ^a  

^a GENERAL HOSPITAL OF NIKEA   (Greece)

^b NONE   (Greece)

Author keywords

Myocardial infarction; Persistent smokers; Smoking cessation

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; EXERCISE; FEMALE; GENERAL HOSPITAL; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INTERVIEW; LIFESTYLE; LIPID ANALYSIS; MALE; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING CESSATION;

EID: 17044405441     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.08.040     Document Type: Article

References (38)

1. Department of Health and Human Services. The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. DHHS Publication (PHS) 84-50204. Washington, DC, Office on Smoking and Health, US Government Printing Office, 1983.
2. R. Doll, and R. Peto Mortality in relation to smoking: 20 years' observations on male British doctors Br. Med. J. 2 1976 1525 1536
3. T. Gordon, W.B. Kannel, D. McGee, and T.R. Dawber Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham Study Lancet 2 1974 1345 1348
4. T.F.M. van Berkel, H. Boersma, J.W. Roos-Hesselink, R.A.M. Erdman, and M.L. Simoons Impact of smoking cessation and smoking interventions in patients with coronary heart disease Eur. Heart J. 20 1999 1773 1782
5. C. Wilhelmsson, J.A. Vedin, D. Elmfeldt, G. Tibblin, and L. Wilhelmsen Smoking and myocardial infarction Lancet 1 1975 415 420
6. I. Goldenberg, M. Jonas, and A. Tenenbaum Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease Arch. Intern. Med. 163 2003 2301 2305
7. J. Lightwood, K.E. Freischmann, and S.A. Glantz Smoking cessation in heart failure: it is never too late J. Am. Coll. Cardiol. 37 2001 1683 1684
8. L.E. Daly, R. Mulcahy, I.M. Graham, and N. Hickey Long term effect on mortality of smoking after unstable angina and myocardial infarction Br. Med. J. 287 1983 324 326
9. J. Tsevat Impact and cost-effectiveness of smoking interventions Am. J. Med. 93 1992 43S 47S
10. J. Lightwood, and S.A. Glantz Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke Circulation 96 1997 1089 1096
11. EUROASPIRE Study Group A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. European Action on Secondary Prevention through Intervention to Reduce Events Eur. Heart J. 18 1997 1569 1582
12. EUROASPIRE II Study Group Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme Eur. Heart J. 22 2001 554 572
13. P.W. Wilson Established risk factors and coronary artery disease: the Framingham Study Am. J. Hypertens. 7 1994 7S 12S
14. L.S. Rallidis, M.G. Zolindaki, V.K. Chatziioakimidis, A.H. Velissaridou, E.S. Konstantellou, and E.G. Papasteriadis High prevalence and suboptimal treatment of risk factors in Greek coronary patients Acta Cardiol. 56 2001 7 15
15. F.H. Zimmerman, A. Cameron, L.D. Fisher, and G. Ng Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry) J. Am. Coll. Cardiol. 26 1995 654 661
16. M. Di Tullio, D. Granata, and E. Taioli Early predictors of smoking cessation after myocardial infarction Clin. Cardiol. 14 1991 809 812
17. K.M. Flegal, R.P. Troiano, E.R. Pamuk, R.J. Kuczmarski, and S.M. Campbell The influence of smoking cessation on the prevalence of overweight in the United States N. Engl. J. Med. 333 1995 1214 1216
18. K.M. Galan, U. Deligonul, M.J. Kern, B.R. Chaitman, and M.G. Vandormael Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty Am. J. Cardiol. 61 1988 260 263
19. A.A. Voors, B.L. van Brussel, H.W. Plokker, S.M. Ernst, N.M. Ernst, and E.M. Koomen Smoking and cardiac events after coronary bypass surgery. A 15-year follow-up Circulation 93 1996 42 47
20. B. Hermanson, G.S. Omenn, R.A. Kronmal, and B.J. Gersh Beneficial six-year outcome of smoking cessation in older men and women with coronary heart disease. Results from the CASS Registry N. Engl. J. Med. 319 1988 1365 1369
21. Q. Qiao, M. Tervahauta, A. Nissinen, and J. Tuomilehto Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men Eur. Heart J. 21 2000 1621 1626
22. D. Balfour, N. Benowitz, K. Fagerstrom, M. Kunze, and U. Keil Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy Eur. Heart J. 21 2000 438 445
23. B. Frei, T.M. Forte, B.N. Ames, and C.E. Cross Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid Biochem. J. 277 1991 133 138
24. A.M. Zeiher, V. Schachinger, and J. Minners Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function Circulation 92 1995 1094 1100
25. P.E. Cryer, M.W. Haymond, J.V. Santiago, and S.D. Shah Norepinephrine and epinephrine release and adrenergic mediation of smoking associated hemodynamic and metabolic events N. Engl. J. Med. 295 1976 573 577
26. D.J. Moliterno, J.E. Willard, and R.A. Lange Coronary artery vasoconstriction induced by cocaine, cigarette smoking, or both N. Engl. J. Med. 330 1994 454 459
27. M.H. Criqui, R.B. Wallace, G. Heiss, M. Mishkel, G. Schonfeld, and G.T. Jones Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study Circulation 62 1980 IV70 IV76
28. A.R. Folsom, K.K. Wu, C.E. Davis, M.G. Conlan, P.D. Sorlie, and M. Szklo Population correlates of plasma fibrinogen and factor VII, protective cardiovascular risk factors Atherosclerosis 91 1991 191 205
29. Y. Fusegawa, S. Goto, S. Handa, T. Kawada, and Y. Ando Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers Thromb. Res. 93 1999 271 278
30. R.P. Tracy, B.M. Psaty, E. Macy, E.G. Bovill, M. Cushman, and E.S. Cornell Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects Arterioscler. Thromb. Vasc. Biol. 17 1997 2167 2176
31. M. Frohlich, M. Sund, H. Lowel, A. Imhof, A. Hoffmeister, and W. Koenig Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95) Eur. Heart J. 24 2003 1365 1372
32. M.R. Adams, W. Jessup, and D.S. Celermajer Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral l-arginine but not vitamin C J. Am. Coll. Cardiol. 29 1997 491 497
33. M.J.F. Kool, A.P.G. Hoeks, H.A.J.S. Boudier, R.S. Reneman, and L.M.A.B. Van Bortel Short- and long-term effects of smoking on arterial wall properties in habitual smokers J. Am. Coll. Cardiol. 22 1993 1881 1886
34. S.J. Schleifer, M.M. Macari-Hinson, and D.A. Coyle The nature and course of depression following myocardial infarction Arch. Intern. Med. 149 1989 1785 1789
35. I.P. Huijbrechts, H.J. Duivenvoorden, J.W. Deckers, I.C. Leenders, G.A. Pop, and J. Passchier Modification of smoking habits five months after myocardial infarction: relationship with personality characteristics J. Psychosom. Res. 40 1996 369 378
36. C. Silagy, D. Mant, G. Fowler, and M. Lodge Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation Lancet 343 1994 139 142
37. A.M. Joseph, S.M. Norman, L.H. Ferry, A.V. Prochazka, E.C. Westman, and B.G. Steele The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease N. Engl. J. Med. 335 1996 1792 1798
38. D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J.A. Johnston, and A.R. Hughes A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N. Engl. J. Med. 340 1999 685 691